Episode 73: The Future of Medicine and Biotech at Tulane (Part 1)
How are researchers at Tulane University School of Medicine tackling some of the world’s most pressing health challenges?
In this episode, host Elaine Hamm, PhD, sits down with Alexis Ducote, PhD, Business Development Associate at Tulane Medicine, to explore the latest medical innovations emerging from Tulane’s research labs. From groundbreaking tuberculosis detection methods to advancements in triple-negative breast cancer research, this conversation dives deep into the intersection of cutting-edge science and real-world impact.
In this episode, you’ll discover:
- The significant link between tuberculosis and HIV, and how dual-diagnostic testing could transform global healthcare.
- The latest research on triple-negative breast cancer and how Tulane scientists are addressing health disparities in at-risk populations.
- How researchers at Tulane are exploring naturally occurring compounds from stressed plants as potential therapeutics, with promising effects on tumor growth inhibition.
Join us as we uncover how Tulane researchers are driving innovation in medicine and shaping the future of healthcare. Keep an eye out for part 2 of this engaging discussion!
Links:
Connect with Alexis Ducote, PhD.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Tony Hu, PhD and check out his startup NanoPin Technologies.
Connect with Bridgette Collins-Burow, MD, PhD and Matthew Burow, PhD.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
